PCI Biotech Holding ASA (OSTO:PCIBO)
kr 1.8 0 (0%) Market Cap: 48.60 Mil Enterprise Value: 18.54 Mil PE Ratio: 0 PB Ratio: 1.52 GF Score: 29/100

Q2 2020 PCI Biotech Holding ASA Earnings Call Transcript

Aug 26, 2020 / 06:30AM GMT
Release Date Price: kr43.2 (-27.76%)
Per Walday
PCI Biotech Holding ASA - CEO

Good morning, and welcome to PCI Biotech Second Quarter First Half 2020 Presentation Webcast here from the Oslo Cancer Cluster Innovation Park. My name is Per Walday. I'm the CEO of PCI Biotech, and I have with me also Ronny Skuggedal who is the CFO of PCI Biotech.

We will start by going through the background, the technology of the company, the company at a glance, then moving into the highlights of the first half of the year. And after that take a deeper look into the 3 different programs and the outlook. And then we will open up for questions through this webcast platform that can be submitted at the end of the presentation.

So with this, let's move over to the PCI Biotech at a glance, what are we. So PCI Biotech is a company built on a platform technology called photochemical internalization, that's PCI. What we do is that we enable intracellular delivery of medicines. We have -- this is a very broad platform that can be used for a number of different applications, but we are focusing primarily on cancer, and we are doing this through 3

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot